These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 29132996)

  • 1. Q-Vax Q fever vaccine failures, Victoria, Australia 1994-2013.
    Bond KA; Franklin LJ; Sutton B; Firestone SM
    Vaccine; 2017 Dec; 35(51):7084-7087. PubMed ID: 29132996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine prophylaxis of Q fever. A follow-up study of the efficacy of Q-Vax (CSL) 1985-1990.
    Ackland JR; Worswick DA; Marmion BP
    Med J Aust; 1994 Jun; 160(11):704-8. PubMed ID: 8202006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine prophylaxis of abattoir-associated Q fever: eight years' experience in Australian abattoirs.
    Marmion BP; Ormsbee RA; Kyrkou M; Wright J; Worswick DA; Izzo AA; Esterman A; Feery B; Shapiro RA
    Epidemiol Infect; 1990 Apr; 104(2):275-87. PubMed ID: 2323360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited humoral and cellular responses to Q fever vaccination in older adults with risk factors for chronic Q fever.
    Schoffelen T; Herremans T; Sprong T; Nabuurs-Franssen M; Wever PC; Joosten LA; Netea MG; van der Meer JW; Bijlmer HA; van Deuren M
    J Infect; 2013 Dec; 67(6):565-73. PubMed ID: 23973626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy of a Coxiella burnetii chloroform:methanol residue (CMR) vaccine and a licensed cellular vaccine (Q-Vax) in rodents challenged by aerosol.
    Waag DM; England MJ; Pitt ML
    Vaccine; 1997 Nov; 15(16):1779-83. PubMed ID: 9364683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Components of protective immunity.
    Zhang G; Zhang Y; Samuel JE
    Adv Exp Med Biol; 2012; 984():91-104. PubMed ID: 22711628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy and immunogenicity of Q fever chloroform:methanol residue (CMR) and phase I cellular (Q-Vax) vaccines in cynomolgus monkeys challenged by aerosol.
    Waag DM; England MJ; Tammariello RF; Byrne WR; Gibbs P; Banfield CM; Pitt ML
    Vaccine; 2002 Jun; 20(19-20):2623-34. PubMed ID: 12057622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural Exposure- and Vaccination-Induced Profiles of
    Raju Paul S; Scholzen A; Mukhtar G; Wilkinson S; Hobson P; Dzeng RK; Evans J; Robson J; Cobbold R; Graves S; Poznansky MC; Garritsen A; Sluder AE
    Front Immunol; 2022; 13():886698. PubMed ID: 35812430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine prophylaxis of abattoir-associated Q fever.
    Marmion BP; Ormsbee RA; Kyrkou M; Wright J; Worswick D; Cameron S; Esterman A; Feery B; Collins W
    Lancet; 1984 Dec; 2(8417-8418):1411-4. PubMed ID: 6151039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of a Q fever vaccination program for high-risk patients in the Netherlands.
    Isken LD; Kraaij-Dirkzwager M; Vermeer-de Bondt PE; Rümke HC; Wijkmans C; Opstelten W; Timen A
    Vaccine; 2013 May; 31(23):2617-22. PubMed ID: 23583810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control strategies for Q fever based on results of pre-vaccination screening in Victoria, 1988 to 2001.
    Greig JE; Patel MS; Clements MS; Taylor NK
    Aust N Z J Public Health; 2005 Feb; 29(1):53-7. PubMed ID: 15782873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abattoir-associated Q fever: a Q fever outbreak during a Q fever vaccination program.
    Gilroy N; Formica N; Beers M; Egan A; Conaty S; Marmion B
    Aust N Z J Public Health; 2001 Aug; 25(4):362-7. PubMed ID: 11529620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cluster of Coxiella burnetii infections associated with exposure to vaccinated goats and their unpasteurized dairy products.
    Fishbein DB; Raoult D
    Am J Trop Med Hyg; 1992 Jul; 47(1):35-40. PubMed ID: 1636881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Q fever vaccine efficacy and occupational exposure risk in Queensland, Australia: A retrospective cohort study.
    Woldeyohannes SM; Perkins NR; Baker P; Gilks CF; Knibbs LD; Reid SA
    Vaccine; 2020 Sep; 38(42):6578-6584. PubMed ID: 32798141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Australia's national Q fever vaccination program.
    Gidding HF; Wallace C; Lawrence GL; McIntyre PB
    Vaccine; 2009 Mar; 27(14):2037-41. PubMed ID: 19428827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Q fever outbreak in a goat herd--diagnostic investigations and measures for control.
    Sting R; Molz K; Benesch C
    Berl Munch Tierarztl Wochenschr; 2013; 126(9-10):394-400. PubMed ID: 24199381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guinea pig abscess/hypersensitivity model for study of adverse vaccination reactions induced by use of Q fever vaccines.
    Wilhelmsen CL; Waag DM
    Comp Med; 2000 Aug; 50(4):374-8. PubMed ID: 11020154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of vaccination by a phase I Coxiella burnetii-inactivated vaccine in goat herds in clinical Q fever situation.
    de Cremoux R; Rousset E; Touratier A; Audusseau G; Nicollet P; Ribaud D; David V; Le Pape M
    FEMS Immunol Med Microbiol; 2012 Feb; 64(1):104-6. PubMed ID: 22066485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experience in vaccinating farm animals for preventing Q fever in humans].
    Lisák V
    Tr Inst Im Pastera; 1989; 66():143-53, 174. PubMed ID: 2485300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Q fever vaccination in Queensland abattoirs.
    Bell M; Patel M; Sheridan J
    Commun Dis Intell; 1997 Feb; 21(3):29-31. PubMed ID: 9079588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.